China Approves the World’s First Vaccine against XBB Descendent Lineages of SARS-CoV-2 for Emergency Use
(Adnkronos) – CHENGDU, China, June 9, 2023 /PRNewswire/ — On June 8th, 2023, Coviccine® Trivalent XBB.1.5-Recombinant COVID-19 Trivalent (XBB.1.5+BA.5+Delta) Protein Vaccine (Sf9 cell) developed by WestVac Biopharma/ West China Medical Center, Sichuan
